ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
DNA 검사 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 10.8%로 302억 5,000만 달러로 성장할 것입니다. 예측 기간의 성장 배경에는 유전성 질환의 증가, DNA 진단의 이용 확대, 헬스케어 인프라의 정비, 질병 예방에 대한 인식 제고, 제조업체의 투자 증가, 동반진단의 채택 확대 등이 있습니다. 예측 기간의 주요 동향으로는 차세대 염기서열분석(NGS), 중합효소 연쇄 반응(PCR), 보조생식기술(ART)의 착상 전 유전자 진단(PGD), 검사기기의 소형화, 신제품, 신규 분석법, 바이오마커, 진단 도구, 현장진단(POCT), 비침습적 산전 검사(NIPT) 개발 등을 들 수 있습니다.
향후 5년간 10.8%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 에스토니아와 덴마크에서 개발된 전장 엑솜 시퀀싱 서비스와 해석 소프트웨어의 가격을 급등시켜 희귀질환 진단 지연과 유전상담 비용 상승을 가져와 임상유전학에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장의 고조와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
유전성 질환의 발병률 증가가 당분간 DNA 검사 시장의 성장을 견인할 것으로 예상됩니다. 유전자 질환은 개인의 DNA 이상에 의해 발생하며, 신체적 또는 발달적 이상을 초래합니다. 유전자 질환의 유병률 증가 요인으로는 인식의 증가, 진단 기술의 발전, 유전자 스크리닝의 확대, 특정 집단의 근친상간 유병률 증가 등을 들 수 있습니다. DNA 검사는 유전자 질환을 가진 개인의 진단, 예후 예측, 치료 결정에 있어 점점 더 중요한 역할을 하고 있으며, 개인의 유전자 프로파일에 기반한 맞춤형 의료 개입과 가족 계획 전략을 촉진하고 있습니다. 예를 들어, 세계보건기구(WHO)가 2023년 2월 발표한 바에 따르면, 선천성 질환은 전 세계적으로 연간 24만 명의 생후 28일 이내 영아 사망을 차지하는 것으로 추정됩니다. 또한, 미국 질병예방통제센터(CDC)에 따르면 미국에서는 매년 약 6,000명의 다운증후군 아동이 태어나고 있으며, 이는 약 700명 중 1명의 비율에 해당합니다. 이처럼 유전성 질환의 유병률 증가는 DNA 검사 시장을 발전시키고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 DNA 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 DNA 검사 시장 : 성장률 분석
세계의 DNA 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 DNA 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 DNA 검사 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 DNA 검사 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
장비
소모품
소프트웨어와 서비스
세계의 DNA 검사 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응(PCR) 기반
ISH(In Situ Hybridization)
마이크로어레이
차세대 시퀀싱(NGS) DNA 진단
세계의 DNA 검사 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
신생아 DNA 스크리닝
출생전 DNA 캐리어 스크리닝
종양 진단과 조직병리학
착상전 진단
감염증 진단
약물유전체학 진단 검사
진단과 법의학 특정
기타 용도
세계의 DNA 검사 시장 : 하위 세분화 기기(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
DNA 분석기
PCR(중합효소 연쇄 반응) 장비
시퀸서
전기영동 시스템
기타 DNA 검사 기기
세계의 DNA 검사 시장 : 하위 세분화 소모품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
시약과 키트
PCR 소모품(프라이머, 프로브)
DNA 추출 키트
샘플 수집 장비
기타(DNA 마커, 전기영동 겔)
세계의 DNA 검사 시장 : 하위 세분화 소프트웨어(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
데이터 분석 소프트웨어
검사 정보 관리 시스템(LIMS)
유전자 분석 소프트웨어
바이오인포매틱스 소프트웨어
기타 DNA 검사 소프트웨어 솔루션
세계의 DNA 검사 시장 : 하위 세분화 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
검사 서비스(유전자 검사, 법의학 검사 등)
데이터 해석 서비스
상담 서비스(유전 상담)
실험실 서비스(샘플 처리, DNA 시퀀싱 서비스)
기타 DNA 검사 서비스
제7장 지역별·국가별 분석
세계의 DNA 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 DNA 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
DNA 검사 시장 : 경쟁 구도
DNA 검사 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Becton, Dickinson and Company
GE HealthCare Technologies Inc.
Laboratory Corporation of America Holdings(LabCorp)
Quest Diagnostics Incorporated
Eurofins Scientific SE
Agilent Technologies
Illumina Inc.
PerkinElmer Inc.
bioMerieux SA
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Natera Inc
Myriad Genetics Inc.
BGI Genomics Co. Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
DNA 검사 시장 2029 : 새로운 기회를 제공하는 국가
DNA 검사 시장 2029 : 새로운 기회를 제공하는 부문
DNA 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
DNA testing involves analyzing an individual's DNA, which contains the instructions for an organism's development, functioning, and traits. This process includes extracting DNA from cells, often obtained from bodily fluids or tissues such as blood, saliva, or hair, and then examining specific regions or sequences of the DNA molecule.
The primary product types in DNA testing include equipment, consumables, software, and services. Equipment comprises various instruments, devices, and tools utilized in the analysis of DNA samples. Various technologies are employed in DNA testing, including polymerase chain reaction (PCR)-based methods, in-situ hybridization, microarray analysis, and next-generation sequencing (NGS) for DNA diagnosis. These techniques find applications across various fields such as newborn DNA screening, prenatal DNA carrier screening, oncology diagnostics, histopathology, pre-implantation diagnosis, infectious disease diagnostics, pharmacogenomics diagnostic testing, identity verification, forensics, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The DNA testing market research report is one of a series of new reports from The Business Research Company that provides DNA testing market statistics, including DNA testing industry global market size, regional shares, competitors with a DNA testing market share, detailed DNA testing market segments, market trends and opportunities, and any further data you may need to thrive in the DNA testing industry. This DNA testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The dna testing market size has grown rapidly in recent years. It will grow from $17.9 billion in 2024 to $20.04 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the increasing incidence of chronic diseases, rising demand for precision medicine, rising direct-to-consumer (DTC) testing, rising demand for population genomics, growing forensic investigations, and demand for genetic screening.
The dna testing market size is expected to see rapid growth in the next few years. It will grow to $30.25 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising incidences of genetic diseases, growing use of DNA diagnostics, growing healthcare infrastructure, growing awareness of disease prevention, rising investment by manufacturers, and increased adoption of companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), miniaturization of testing devices, new DNA testing products, and development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).
The forecast of 10.8% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder clinical genetics by inflating prices of whole exome sequencing services and interpretation software developed in Estonia and Denmark, resulting in delayed rare disease diagnoses and higher genetic counseling costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of genetic disorders is anticipated to drive the growth of the DNA testing market in the foreseeable future. Genetic disorders result from abnormalities in an individual's DNA, leading to physical or developmental anomalies. Factors contributing to the increasing prevalence of genetic disorders include heightened awareness, advancements in diagnostic techniques, expanded genetic screening, and a growing prevalence of consanguineous marriages in certain populations. DNA testing plays an increasingly vital role in diagnosing, prognosticating, and making treatment decisions for individuals with genetic disorders, facilitating personalized medical interventions and family planning strategies based on an individual's genetic profile. For example, as per the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 infant deaths worldwide within 28 days of birth annually. Additionally, according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States each year, equating to around 1 in every 700 births. Thus, the escalating prevalence of genetic disorders is propelling the DNA testing market forward.
Key players in the DNA testing market are concentrating on developing advanced testing solutions such as precancer detection DNA tests to enhance early cancer diagnosis and treatment. Precancer detection DNA tests are diagnostic assays designed to detect genetic alterations or biomarkers associated with the early stages of cancer development. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company specializing in esophageal cancer prevention diagnostics, introduced EsoGuard 2.0, the next-generation EsoGuard Esophageal DNA Test. This advanced DNA test employs molecular techniques and enhanced sample DNA yields to improve assay performance and reduce costs. The test involves collecting esophageal cell DNA using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to identify methylation at specific gene sites linked to esophageal precancer and cancer. Providing results indicating the presence or absence of epigenetic changes consistent with esophageal precancer and cancer, this DNA test is pivotal in cancer prevention and early detection efforts.
In June 2022, Zoetis Inc., a US-based company specializing in animal health products, acquired Basepaws for an undisclosed amount. This acquisition enables Zoetis to enhance its precision animal health portfolio by incorporating Basepaws' genetic testing services, which offer valuable insights into pet health and disease predispositions. Basepaws boasts one of the largest feline genomic and oral microbiome databases in the world, which will bolster Zoetis' research and development efforts and contribute to future advancements in pet care products. Basepaws is a US-based company known for its DNA testing services for cats.
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the DNA testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The DNA testing market consists of revenues earned by entities by providing services such as paternity testing, maternity testing, genetic health risk assessment, carrier screening, pharmacogenomics testing, forensic DNA analysis, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA testing market also includes sales of sterile swabs, DNA collection kits, thermal cyclers, DNA sequencers, microarray platforms, DNA extraction kits, polymerase chain reaction (PCR) reagents, and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
DNA Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dna testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for dna testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Equipment; Consumables; Software And Services
2) By Technology: Polymerase Chain Reaction (PCR) Based; In-Situ Hybridization; Microarray; Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening; Pre-Natal DNA Carrier Screening; Oncology Diagnostics And Histopathology; Pre-implantation Diagnosis; Infectious Disease Diagnostics; Pharmacogenomics Diagnostic Testing; Identify Diagnostics And Forensic; Other Applications
Subsegments:
1) By Equipment: DNA Analyzers; PCR (Polymerase Chain Reaction) Machines; Sequencers; Electrophoresis Systems; Other DNA Testing Instruments
2) By Consumables: Reagents And Kits; PCR Consumables (Primers, Probes); DNA Extraction Kits; Sample Collection Devices; Others (DNA Markers, Electrophoresis Gels)
3) By Software: Data Analysis Software; Laboratory Information Management System (LIMS); Genetic Analysis Software; Bioinformatics Software; Other DNA Testing Software Solutions
4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.); Data Interpretation Services; Consultation Services (Genetic Counseling); Laboratory Services (Sample Processing, DNA Sequencing Services); Other DNA Testing Services
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. DNA Testing Market Characteristics
3. DNA Testing Market Trends And Strategies
4. DNA Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global DNA Testing Growth Analysis And Strategic Analysis Framework
5.1. Global DNA Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global DNA Testing Market Growth Rate Analysis
5.4. Global DNA Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global DNA Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global DNA Testing Total Addressable Market (TAM)
6. DNA Testing Market Segmentation
6.1. Global DNA Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Equipment
Consumables
Software And Services
6.2. Global DNA Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Based
In-Situ Hybridization
Microarray
Next-Generation Sequencing (NGS) DNA Diagnosis
6.3. Global DNA Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Newborn DNA Screening
Pre-Natal DNA Carrier Screening
Oncology Diagnostics And Histopathology
Pre-implantation Diagnosis
Infectious Disease Diagnostics
Pharmacogenomics Diagnostic Testing
Identify Diagnostics And Forensic
Other Applications
6.4. Global DNA Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Analyzers
PCR (Polymerase Chain Reaction) Machines
Sequencers
Electrophoresis Systems
Other DNA Testing Instruments
6.5. Global DNA Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
PCR Consumables (Primers, Probes)
DNA Extraction Kits
Sample Collection Devices
Others (DNA Markers, Electrophoresis Gels)
6.6. Global DNA Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Laboratory Information Management System (LIMS)
Genetic Analysis Software
Bioinformatics Software
Other DNA Testing Software Solutions
6.7. Global DNA Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
